The gliadin p31–43 peptide: Inducer of multiple proinflammatory effects

Abstract

Coeliac disease (CD) is the prototype of an inflammatory chronic disease induced by food. In this context, gliadin p31–43 peptide comes into the spotlight as an important player of the inflammatory/innate immune response to gliadin in CD. The p31–43 peptide is part of the p31–55 peptide from α-gliadins that remains undigested for a long time, and can be present in the small intestine after ingestion of a gluten-containing diet. Different biophysical methods and molecular dynamic simulations have shown that p31–43 spontaneously forms oligomeric nanostructures, whereas experimental approaches using in vitro assays, mouse models, and human duodenal tissues have shown that p31–43 is able to induce different forms of cellular stress by driving multiple inflammatory pathways. Increased proliferative activity of the epithelial cells in the crypts, enterocyte stress, activation of TG2, induction of Ca2 +, IL-15, and NFκB signaling, inhibition of CFTR, alteration of vesicular trafficking, and activation of the inflammasome platform are some of the biological effects of p31–43, which, in the presence of appropriate genetic susceptibility and environmental factors, may act together to drive CD.